Gene · 554
Papers2,697
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,697
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modulation of social behavior by distinct vasopressin sources. | Front Endocrinol (Lausanne) | 2023 | 36860367 | PubTator, text mining | PubMed |
| Structural details of a Class B GPCR-arrestin complex revealed by genetically encoded crosslinkers in living cells. | Nat Commun | 2023 | 36859440 | PubTator, text mining | PubMed |
| Molecular Engineering of Near-Infrared Fluorescent Probes for Cell Membrane Imaging. | Molecules | 2023 | 36838896 | PubTator, text mining | PubMed |
| Hyponatremia and Cancer: From Bedside to Benchside. | Cancers (Basel) | 2023 | 36831539 | PubTator, text mining | PubMed |
| Vestibular Disorders and Hormonal Dysregulations: State of the Art and Clinical Perspectives. | Cells | 2023 | 36831323 | PubTator, text mining | PubMed |
| Report from the 28th Meeting on Toxinology, "Toxins: What's up, Doc?", Organized by the French Society of Toxinology on 28-29 November 2022. | Toxins (Basel) | 2023 | 36828440 | PubTator, text mining | PubMed |
| Wordom update 2: A user-friendly program for the analysis of molecular structures and conformational ensembles. | Comput Struct Biotechnol J | 2023 | 36817953 | PubTator, text mining | PubMed |
| In vitro delivery of mTOR inhibitors by kidney-targeted micelles for autosomal dominant polycystic kidney disease. | SLAS Technol | 2023 | 36804177 | PubTator, text mining | PubMed |
| Functional TFEB activation characterizes multiple models of renal cystic disease and loss of polycystin-1. | Am J Physiol Renal Physiol | 2023 | 36794754 | PubTator, text mining | PubMed |
| The case for standardizing gene nomenclature in vertebrates. | Nature | 2023 | 36792746 | PubTator, text mining | PubMed |
| Idiopathic partial central diabetes insipidus. | Einstein (Sao Paulo) | 2023 | 36790249 | PubTator, text mining | PubMed |
| Efficacy and safety of tolvaptan for refractory fluid collection and edema in the terminal cancer patients. | Fujita Med J | 2023 | 36789131 | PubTator, text mining | PubMed |
| Design of two ongoing clinical trials of tolvaptan in the treatment of pediatric patients with autosomal recessive polycystic kidney disease. | BMC Nephrol | 2023 | 36782137 | PubTator, text mining | PubMed |
| Morbidity Associated with Chronic Hyponatremia. | J Clin Med | 2023 | 36769626 | PubTator, text mining | PubMed |
| Insights of Endocytosis Signaling in Health and Disease. | Int J Mol Sci | 2023 | 36769293 | PubTator, text mining | PubMed |
| Functional and Molecular Markers for Hearing Loss and Vertigo Attacks in Meniere's Disease. | Int J Mol Sci | 2023 | 36768827 | PubTator, text mining | PubMed |
| The Role of Arginine-Vasopressin in Stroke and the Potential Use of Arginine-Vasopressin Type 1 Receptor Antagonists in Stroke Therapy: A Narrative Review. | Int J Mol Sci | 2023 | 36768443 | PubTator, text mining | PubMed |
| Loss of Pten in Renal Tubular Cells Leads to Water Retention by Upregulating AQP2. | Kidney Dis (Basel) | 2023 | 36756085 | PubTator, text mining | PubMed |
| The genetic landscape of autosomal dominant polycystic kidney disease in Kuwait. | Clin Kidney J | 2023 | 36755831 | PubTator, text mining | PubMed |
| Structure-Affinity and Structure-Kinetic Relationship Studies of Benzodiazepine Derivatives for the Development of Efficacious Vasopressin V2 Receptor Antagonists. | J Med Chem | 2023 | 36732931 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/554/papers?page=18